Laranjo, Amado G.
HRN: 15-47-83 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/23/2025
CEFTAZIDIME 1GM (VIAL)
10/23/2025
10/30/2025
IV
1g
Q8h
Cap-MR
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes